ArticleFrontiers in bioengineering and biotechnology2026
Hypoxia preconditioned serum (HPS) and platelet-rich plasma (PRP) promote proliferation, neurite network formation, and neurite elaboration in N2a cells.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The use of autologous growth factors, such as those contained in Hypoxia-Preconditioned Serum (HPS) and Platelet-Rich Plasma (PRP), represents a promising strategy to enhance regenerative processes in injured nerves. As an initial Methods: HPS and PRP were first compared with normal serum (NS) using a protein microarray to detect neurologically related growth factors. Subsequently, N2a cells were cultured with three different secretome concentrations (0.1%, 1%, and 10%) for up to 96 h and analyzed for proliferation (cell counting), viability (Alamar Blue), cytotoxicity (LDH assay), combined proliferation and migration (scratch assay), and neurite outgrowth. Results: Microarray analysis identified 30 neurotrophic, regulatory, and inflammatory factors in both HPS and PRP. Compared with PRP, HPS contained significantly higher levels of BDNF, CNTF, and VEGF-A, as well as the regulatory factors IL-6, TGF-β, and LIF. Several neurodegeneration-associated markers, including FAS, TNF-α, and IL-8, were also elevated in HPS. Proliferation and migration were most strongly stimulated by the 1% concentration of HPS and PRP, which also maintained high viability and low cytotoxicity. After 96 h, both PRP and HPS markedly enhanced neurite outgrowth by increasing total neurite count, neurite length, neurite-covered area, and branching points. PRP-0.1% and -1% produced the strongest effects, with up to 1.7-fold higher values across assessed parameters than the negative control, whereas HPS-0.1% increased these parameters by up to 1.4-fold. Further analyses demonstrated that these effects occurred alongside marked cell proliferation. Although the proportion of neurite-bearing cells (NBCs) declined over time because total cell expansion outpaced the increase in NBCs, normalization of neurite parameters to NBCs revealed up to 1.7-fold increases in neurite count, neurite length, neurite-covered area, and branching points per NBC, with the strongest effects observed in HPS-0.1% and PRP-0.1%. Conclusion: HPS and PRP promoted expansion of the neurite network while enhancing neurite elaboration of NBCs despite pronounced proliferative effects. These findings identify HPS and PRP as biologically active secretomes with potential to support neuronal structural remodeling, warranting investigation in primary neuronal cultures and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.